Intravitreal drug delivery has become a popular method of treatment of many retinal diseases, commonly including AMD, Diabetic Retinopathy, and Retinal Vein Occlusions.
Intravitreal Injectables Market contains market size and forecasts of Intravitreal (IVT) Injectables in global, including the following market information:
- Global Intravitreal (IVT) Injectables Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Intravitreal (IVT) Injectables Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intravitreal (IVT) Injectables companies in 2021 (%)
The global Intravitreal (IVT) Injectables market was valued at 14950 million in 2021 and is projected to reach US$ 23480 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-VEGF Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intravitreal (IVT) Injectables include Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, Alimera Sciences, ThromboGenics and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravitreal (IVT) Injectables manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravitreal (IVT) Injectables Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal (IVT) Injectables Market Segment Percentages, by Type, 2021 (%)
- Anti-VEGF
- Corticosteroids
- Antibiotics
- Antivirals
- Antifungals
Global Intravitreal (IVT) Injectables Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal (IVT) Injectables Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
- Others
Global Intravitreal (IVT) Injectables Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal (IVT) Injectables Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Intravitreal (IVT) Injectables revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Intravitreal (IVT) Injectables revenues share in global market, 2021 (%)
- Key companies Intravitreal (IVT) Injectables sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Intravitreal (IVT) Injectables sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Regeneron Pharmaceuticals
- Bausch & Lomb
- Novartis
- Allergan
- Alimera Sciences
- ThromboGenics
- Bristol-Myers Squibb
Industry Market Size
